I believe that Dr. Greenwood is continuing to use the CCS terminology, and I can’t see any substantial difference between the NovoSkin CCS and the CCS mentioned within Dr. Greenwood’s Skin Tissue Engineering venture. (See Dr. Greenwood’s linkdin profile)
I am certain that what has happened is that PolyNovo is concentrating on its core business and is leaving bioreactors etc. to Dr. Greenwood. I expect that there will be a significant level of coordination and cooperation between PolyNovo and Skin T.E. as I believe that Dr. Greenwood will continue to use a NovoSorb scaffold.
In short, while there may have been a rejiggering of the relationship between Dr. Greenwood and PolyNovo with respect to the CCS, I don’t think the CCS itself has changed much, although it could be subject to continuous improvement.
- Forums
- ASX - By Stock
- What Dr John had to say
I believe that Dr. Greenwood is continuing to use the CCS...
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.38 |
Change
-0.030(1.24%) |
Mkt cap ! $1.642B |
Open | High | Low | Value | Volume |
$2.42 | $2.44 | $2.36 | $4.288M | 1.798M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 28177 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 26895 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2525 | 2.360 |
6 | 28060 | 2.350 |
2 | 2993 | 2.340 |
2 | 3602 | 2.330 |
1 | 2102 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.400 | 2525 | 1 |
2.410 | 2525 | 1 |
2.420 | 19143 | 4 |
2.430 | 2525 | 1 |
2.440 | 14572 | 4 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online